Lansdale, PA, United States of America

Ernest Dale Lehman

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernest Dale Lehman. Retrieved from https://idiyas.com/inventor/ernest-dale-lehman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ernest Dale Lehman

Introduction

Ernest Dale Lehman is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His work has had a profound impact on public health and disease prevention.

Latest Patents

Lehman holds a patent for recombinant papillomavirus vaccines. This patent includes recombinant expression vectors encoding the L1 and L2 proteins of papillomavirus, methods of making and using the recombinant proteins, and purified virus-like particles comprised of the recombinant proteins. This innovation is crucial for advancing vaccine technology and improving health outcomes.

Career Highlights

Lehman is associated with Merck & Company, Inc., a leading global healthcare company. His role at Merck has allowed him to work on groundbreaking research and development projects that aim to combat infectious diseases.

Collaborations

Throughout his career, Lehman has collaborated with esteemed colleagues, including Kathrin Ute Jansen and James C Cook, III. These partnerships have fostered innovation and have been instrumental in the success of various projects.

Conclusion

Ernest Dale Lehman is a distinguished inventor whose work in recombinant papillomavirus vaccines exemplifies the importance of innovation in healthcare. His contributions continue to influence the field and improve the lives of many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…